Microchip Implant Makes Remote-Controlled Drug Delivery Possible

A remote-controlled microchip that’s implanted in patients and programmed to release medication on schedule worked in its first trial, validating a new approach that could help improve drug management in chronic diseases.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.